How common are antibodies against Sars-CoV-2 in people in Freiburg and the Breisgau-Hochschwarzwald district? This is determined by a study that has now started.
The Helmholtz Center for Infection Research (HZI) wants to find out throughout Germany how many people have already contracted Covid-19. Up to 3000 randomly selected people from Freiburg and the Breisgau-Hochschwarzwald district will be interviewed and given a blood sample. The head of the study, Gérard Krause, is satisfied with the start of this week in the Freiburg city hall. The first results could be published in autumn.
The aim of the study
“Antibodies can be used to prove whether a certain disease has already been run through,” explains Krause, an epidemiologist from the HZI. How widespread the Sars-cov-2 virus was and still is in the population is a representative …
–
–
